What exactly is happening inside a dog's spinal cord with DM?

Degenerative myelopathy is a progressive breakdown of the white matter tracts in the spinal cord — the axons and myelin sheaths that carry movement and sensory signals between the brain and the hind limbs. The damage typically begins in the thoracic spinal cord and spreads over months, which is why the disease has often been compared to amyotrophic lateral sclerosis (ALS) in humans, though the underlying biology differs (Cornell Riney Canine Health Center, n.d.). Because the disease affects nerve conduction rather than pain-sensing structures, dogs with DM are not thought to experience spinal pain from the condition itself, which is one of the clues veterinarians use to distinguish it from a herniated disc.

The disease is linked to a mutation in the SOD1 gene (superoxide dismutase 1), the same gene implicated in some familial forms of ALS in people. Dogs that inherit two copies of the mutated gene are considered at risk, though not every dog with the mutation goes on to develop clinical signs, and researchers at the University of Missouri and the Broad Institute who helped identify the mutation continue to study why some carriers never progress to disease (Orthopedic Foundation for Animals, n.d.).

What's the first thing owners usually notice?

The earliest sign is almost always a subtle asymmetry in the hind end: one back paw scuffing or knuckling under during a walk, nails on one foot wearing down unevenly, or a slight sway in the hips at a trot. Because DM affects one side of the spinal cord more than the other in most dogs, the weakness is frequently more obvious on one leg before it becomes bilateral (Merck Veterinary Manual, 2024). Owners often describe it as their dog looking "drunk" in the back half, or losing footing on smooth floors like tile or hardwood before it shows up on grass or carpet.

Over the following six to twelve months, this progresses to more obvious hind-limb weakness, difficulty rising from a lying position, and eventually dragging of the rear legs. Because the onset is gradual and painless, many owners initially attribute it to arthritis or normal aging, which delays a workup — a pattern veterinary neurologists specifically flag as a reason to bring even mild new hind-end unsteadiness to a veterinarian promptly (American College of Veterinary Internal Medicine, n.d.).

Which breeds and ages are most at risk?

German Shepherd Dogs are the breed most classically associated with DM, but the SOD1 mutation and clinical disease have also been documented in Boxers, Pembroke and Cardigan Welsh Corgis, Chesapeake Bay Retrievers, Rhodesian Ridgebacks, Wire Fox Terriers, and Bernese Mountain Dogs, among others (Cornell Riney Canine Health Center, n.d.). Mixed-breed dogs with ancestry from these lines can also carry the mutation and develop the disease, which is why breed alone is never a substitute for genetic testing when a family history is known.

Clinical signs typically emerge in dogs eight years of age or older, though the disease can occasionally appear earlier. Because early signs overlap so heavily with normal geriatric slowing and orthopedic disease, breed predisposition is one of the strongest reasons a veterinarian will move DM up the differential list for an aging German Shepherd or Corgi with new rear-limb weakness (Orthopedic Foundation for Animals, n.d.).

How do vets actually diagnose degenerative myelopathy?

There is no single test that confirms DM in a living dog; it is a diagnosis of exclusion. A veterinary neurologist typically starts with a full neurologic exam looking for proprioceptive deficits (a dog's ability to sense limb position) that are worse in the hind limbs, then uses advanced imaging — usually MRI of the spine — to rule out conditions that mimic DM and are treatable, such as intervertebral disc herniation, spinal tumors, or lumbosacral stenosis (Merck Veterinary Manual, 2024).

A DNA saliva or blood test for the SOD1 mutation, available through laboratories such as the Orthopedic Foundation for Animals, can show whether a dog is at risk, a carrier, or clear, but a positive result alone does not confirm active disease since some at-risk dogs never develop symptoms (Orthopedic Foundation for Animals, n.d.). Definitive diagnosis technically requires histopathology of spinal cord tissue after death, which is why the combination of breed, age, symmetric progressive weakness, a clean MRI, and a positive genetic test is used to build a strong presumptive diagnosis in living dogs.

Is there any treatment that slows DM down?

No medication, supplement, or surgery has been proven in controlled studies to halt or reverse degenerative myelopathy's progression. What does have a documented benefit is physical therapy: a widely cited study following DM-affected dogs found that those receiving regular, intensive physiotherapy survived roughly twice as long — around 255 days compared to about 130 days in dogs with minimal or no physical therapy — before losing the ability to walk (Cornell Riney Canine Health Center, n.d.). This has made rehabilitation, not medication, the backbone of managing the disease.

Rehabilitation plans built by a certified canine rehabilitation therapist typically combine underwater treadmill sessions, range-of-motion exercises, balance work, and targeted strengthening of the remaining functional muscle groups. Some neurologists also recommend assistive devices such as rear-support harnesses fairly early, both to prevent falls and to maintain the dog's confidence and activity level while strength remains (American College of Veterinary Internal Medicine, n.d.).

What does day-to-day home care look like as the disease progresses?

As hind-limb function declines, home management shifts toward preventing secondary problems: pressure sores from lying in one position too long, urine scald from incontinence, and joint injuries from dragging or knuckling paws. Non-slip runners on hardwood and tile floors, orthopedic bedding, and booties to protect the tops of the paws from abrasion are standard recommendations from veterinary rehabilitation specialists (Merck Veterinary Manual, 2024).

Many owners transition to a wheeled mobility cart once hind-limb paralysis sets in, which allows dogs to remain active and mentally engaged well after they lose the ability to walk unassisted. Bladder and bowel management also becomes central to care, since DM eventually affects the nerves controlling continence in a majority of dogs, and owners are typically taught manual bladder expression techniques by their veterinary team to prevent urinary tract infections (American College of Veterinary Internal Medicine, n.d.).

What's the realistic long-term outlook after diagnosis?

Degenerative myelopathy is ultimately progressive and there is no cure, but the timeline varies considerably by dog and by how aggressively rehabilitation is pursued. Most dogs lose the ability to walk on their hind legs within roughly six to eighteen months of the first noticeable signs, and in dogs who survive long enough, the disease can eventually progress cranially to affect the forelimbs and, in advanced cases, the muscles involved in swallowing and breathing (Merck Veterinary Manual, 2024).

Quality-of-life decisions in DM are less about pain, since the disease itself is not painful, and more about mobility, continence, and the practical burden of nursing care on the household. Veterinary neurologists generally recommend regular reassessment appointments as the disease advances so that owners and their veterinary team can adjust equipment, rehabilitation intensity, and end-of-life planning together rather than reactively (Cornell Riney Canine Health Center, n.d.).